Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study

Abstract Background Microparticles (MPs) are small (<1 μm) cell membrane-derived vesicles that are formed in response to cellular activation or early stages of apoptosis. Increased plasma MP levels have been associated with liver disease severity. Here we investigated the clinical impact of ascit...

Full description

Bibliographic Details
Main Authors: Cornelius Engelmann, Katrin Splith, Sandra Krohn, Adam Herber, Albrecht Boehlig, Stephan Boehm, Johann Pratschke, Thomas Berg, Moritz Schmelzle
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12967-017-1288-3
_version_ 1819022717229203456
author Cornelius Engelmann
Katrin Splith
Sandra Krohn
Adam Herber
Albrecht Boehlig
Stephan Boehm
Johann Pratschke
Thomas Berg
Moritz Schmelzle
author_facet Cornelius Engelmann
Katrin Splith
Sandra Krohn
Adam Herber
Albrecht Boehlig
Stephan Boehm
Johann Pratschke
Thomas Berg
Moritz Schmelzle
author_sort Cornelius Engelmann
collection DOAJ
description Abstract Background Microparticles (MPs) are small (<1 μm) cell membrane-derived vesicles that are formed in response to cellular activation or early stages of apoptosis. Increased plasma MP levels have been associated with liver disease severity. Here we investigated the clinical impact of ascites MPs in patients with decompensated liver cirrhosis. Methods Ascites and blood samples of 163 patients with cirrhosis (ascites n = 163, blood n = 31) were collected between February 2011 and December 2012. MPs were obtained from ascites and from blood by two-step ultracentrifugation and quantified by flow cytometry. Quantitative absolute MP levels were correlated with clinical and laboratory baseline parameters as well as patient outcomes. Ascites microparticles were stained with antibodies against CD66b (neutrophils) and CD3 (lymphocytes) in a subgroup of 60 matched patients. Results MPs were detected in all ascites and blood samples. Absolute ascites MP levels correlated with blood levels (r = 0.444, p = 0.011). Low ascites MP levels (<488.4 MP/μL) were associated with a poor 30-day survival probability (<488.4 MP/μL 71.1% vs. >488.4 MP/μL 94.7%, log rank p = 0.001) and such patients had a higher relative amount of ascites microparticles derived from neutrophils and lymphocytes. Low levels of ascites MPs, high MELD score and antibiotic treatment were independent risk factors for death within 30 days. Conclusions Ascites MP levels predict short-term survival along with the liver function in patients with decompensated cirrhosis. Further studies which evaluate ascites MPs as disease specific biomarker with a validation cohort and which investigate its underlying mechanisms are needed. Neutrophils and lymphocytes contributed more frequently to the release of microparticles in patients with low ascites levels, possibly indicating an immune activation in this cohort.
first_indexed 2024-12-21T04:27:26Z
format Article
id doaj.art-525c94c5cd3c4dfab587f27e6741e903
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-21T04:27:26Z
publishDate 2017-09-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-525c94c5cd3c4dfab587f27e6741e9032022-12-21T19:16:01ZengBMCJournal of Translational Medicine1479-58762017-09-0115111010.1186/s12967-017-1288-3Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort studyCornelius Engelmann0Katrin Splith1Sandra Krohn2Adam Herber3Albrecht Boehlig4Stephan Boehm5Johann Pratschke6Thomas Berg7Moritz Schmelzle8Section of Hepatology, Department of Internal Medicine, Neurology, Dermatology, University Hospital LeipzigDepartment of Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin BerlinSection of Hepatology, Department of Internal Medicine, Neurology, Dermatology, University Hospital LeipzigSection of Hepatology, Department of Internal Medicine, Neurology, Dermatology, University Hospital LeipzigSection of Hepatology, Department of Internal Medicine, Neurology, Dermatology, University Hospital LeipzigKlinische Virologie, Max von Pettenkofer-Institut, Medizinische Fakultät, Ludwig-Maximilians-Universität MünchenDepartment of Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin BerlinSection of Hepatology, Department of Internal Medicine, Neurology, Dermatology, University Hospital LeipzigDepartment of Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin BerlinAbstract Background Microparticles (MPs) are small (<1 μm) cell membrane-derived vesicles that are formed in response to cellular activation or early stages of apoptosis. Increased plasma MP levels have been associated with liver disease severity. Here we investigated the clinical impact of ascites MPs in patients with decompensated liver cirrhosis. Methods Ascites and blood samples of 163 patients with cirrhosis (ascites n = 163, blood n = 31) were collected between February 2011 and December 2012. MPs were obtained from ascites and from blood by two-step ultracentrifugation and quantified by flow cytometry. Quantitative absolute MP levels were correlated with clinical and laboratory baseline parameters as well as patient outcomes. Ascites microparticles were stained with antibodies against CD66b (neutrophils) and CD3 (lymphocytes) in a subgroup of 60 matched patients. Results MPs were detected in all ascites and blood samples. Absolute ascites MP levels correlated with blood levels (r = 0.444, p = 0.011). Low ascites MP levels (<488.4 MP/μL) were associated with a poor 30-day survival probability (<488.4 MP/μL 71.1% vs. >488.4 MP/μL 94.7%, log rank p = 0.001) and such patients had a higher relative amount of ascites microparticles derived from neutrophils and lymphocytes. Low levels of ascites MPs, high MELD score and antibiotic treatment were independent risk factors for death within 30 days. Conclusions Ascites MP levels predict short-term survival along with the liver function in patients with decompensated cirrhosis. Further studies which evaluate ascites MPs as disease specific biomarker with a validation cohort and which investigate its underlying mechanisms are needed. Neutrophils and lymphocytes contributed more frequently to the release of microparticles in patients with low ascites levels, possibly indicating an immune activation in this cohort.http://link.springer.com/article/10.1186/s12967-017-1288-3CirrhosisAscitesMicroparticlesMP
spellingShingle Cornelius Engelmann
Katrin Splith
Sandra Krohn
Adam Herber
Albrecht Boehlig
Stephan Boehm
Johann Pratschke
Thomas Berg
Moritz Schmelzle
Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
Journal of Translational Medicine
Cirrhosis
Ascites
Microparticles
MP
title Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
title_full Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
title_fullStr Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
title_full_unstemmed Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
title_short Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
title_sort absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis a cohort study
topic Cirrhosis
Ascites
Microparticles
MP
url http://link.springer.com/article/10.1186/s12967-017-1288-3
work_keys_str_mv AT corneliusengelmann absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT katrinsplith absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT sandrakrohn absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT adamherber absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT albrechtboehlig absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT stephanboehm absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT johannpratschke absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT thomasberg absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy
AT moritzschmelzle absolutequantificationofmicroparticlesbyflowcytometryinascitesofpatientswithdecompensatedcirrhosisacohortstudy